Clinical Trial

Therapeutic Plasma Exchange in Septic Shock: A Pilot Study

Study acronym: PLEXSIS
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The investigators propose to conduct a multi-center randomized pilot feasibility trial comparing therapeutic plasma exchange to standard of care in patients diagnosed with septic shock.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-10-12; most recent amendment 2025-08-12.
Status change: Not Yet Recruiting → Recruiting 2024-04-03
Trial Details
NCT Number NCT05093075
Lead Sponsor University of Manitoba
Collaborators: Canadian Institutes of Health Research (CIHR), Health Sciences Centre Foundation, Manitoba, McMaster University, University of Toronto
Conditions Septic Shock
Enrollment 80 participants
Start Date 2023-06-01
Primary Completion 2027-03 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-17